FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and can be applied for treatment of liver failure. Transplant includes heterogenic biocompatible biodegradable gel, which has total volume not less than 0.1 ml and the smallest linear size not less than 0.2 mm, pore size 30-500 mcm, total porosity 50-98%, implanted on it autologous progenitor cells of bone marrow after their cultivation in vitro and cultivated autologous liver cells, concentration of liver and bone marrow cells being 2×106-15×106 cells per of 1 cm3 of heterogeneous gel and ratio of bone marrow cells to liver cells being from 1:1 to 1:4. In method of treating liver failure transplant is placed into parenchyma of liver and/or mesentery of small intestine.
EFFECT: group of inventions makes it possible to increase term of cell survival, activate their proliferation.
4 cl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425645C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425647C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425648C1 |
TREATMENT METHOD OF LIVE FAILURE | 2016 |
|
RU2618989C1 |
METHOD OF DISTANT HEPATOCYTE REGENERATION STIMULATION | 2015 |
|
RU2590859C1 |
METHOD OF TREATING HEPATIC FAILURE | 2015 |
|
RU2586952C1 |
CELL PRODUCT FOR TREATING AND CORRECTING HEPATIC IMPAIRMENT | 2012 |
|
RU2510833C1 |
METHOD OF TREATING ACUTE HEPATIC IMPAIRMENT | 2018 |
|
RU2701792C1 |
BIOTRANSPLANT, TREATMENT METHOD OF CHRONIC LIVER DISEASES AND TREATMENT METHOD OF LIVER CIRRHOSIS AND PORTAL HYPERTENSION | 2007 |
|
RU2368384C2 |
METHOD OF TREATMENT OF ACUTE LIVER FAILURE | 2020 |
|
RU2744846C1 |
Authors
Dates
2011-08-10—Published
2010-03-18—Filed